Prognosis of metastatic bone cancer and myeloma patients and long-term risk of medication-related osteonecrosis of the jaw (MRONJ): some critical pointsSupportive Care in Cancer -doi:10.1007/s00520-022-07214-zSpringer Berlin HeidelbergSupportive care in cancer : official journal of the Multinational...
reported that the incidence of localized prostate cancer declined across age groups from 2012 to 2015, however, the incidence of distant metastatic disease increased gradually17. These metastases are associated with poor prognosis, bone pain, and pathological characteristics and indicate the incurability ...
For more advanced cancers, functional status has consistently demonstrated an association with survival, although length of survival may depend on the underlying cancer. For example, for patients with metastatic cancer with relatively good treatment options, such as prostate or breast cancer, prognosis ...
Among all enrolled cases, the moderately differentiated tumors(grade Ⅱ) accounted for 12.50%, and those with poor differentiation(grade Ⅲ) for 25.55%. The major histological subtype was adenocarcinoma, accounting for 72.52%. The most common single metastatic site was bone(22.43%), and the least...
Objectives The aim of this study was to find out the prognosis of medication‐related osteonecrosis of the jaws (MRONJ) in prostate cancer patients who received two different types of antiresorptive agents for bone metastasis. Materials and Methods We retrospectively surveyed a cohort of 95 ...
Breast cancer: metastatic patterns and their prognosis. From 1969 to 1977, metastatic disease developed in 145 of the 558 patients treated for breast cancer at the University of Maryland Medical System. The most... V Patanaphan,OM Salazar,R Risco - 《Southern Medical Journal》 被引量: 425...
11 To our knowledge, all studies evaluating luminal/basal subtypes within prostate cancer have been limited to primary prostate cancer tissue, in part due to the difficulties in obtaining biopsies from metastases, which are often confined to bone. Metastatic castration-resistant prostate cancer (mCRPC...
Functional radiological studies (bone scan, 131I-mIBG, 18F-FDG-PET/CT) performed in 10 patients with spinal metastatic lesions revealed abnormal concentrations of 18F-FDG within the lesions. Bone scanning was performed in seven patients, which was also helpful for detecting the number and nature ...
A software tool to automatically calculate how extensively bones have been infiltrated by prostate cancer is both accurate and speedy, capturing key prognostic information related to survival and the development of symptoms over time. The software, called the automated bone scan index, was te...
Cancer Res. 71, 1263–1271 (2011). Article CAS PubMed Google Scholar Lereclus, E. et al. A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen. BMC Cancer 17, 220 (2017)...